Welcome to our dedicated page for MetLife SEC filings (Ticker: MET), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MetLife, Inc. filings document the regulatory record of a Delaware financial services company with NYSE-listed common stock and preferred securities, including depositary shares tied to Series E and Series F preferred stock. Recent Form 8-K reports furnish earnings releases, quarterly financial supplements, total assets under management fact sheets and Regulation FD disclosures related to variable investment income.
The filings also cover capital-structure actions such as subordinated debenture issuance and preferred stock dividend declarations. Proxy materials describe board composition, committee assignments, executive compensation and shareholder voting matters, while material-event reports record governance changes and other corporate disclosures.
MetLife, Inc. reported a director stock award. Non-management director Michelle Seitz acquired 273 shares of MetLife common stock on a grant basis, with a reported price of $0.00 per share.
After this award, she directly holds 273 common shares, reflecting compensation paid in stock under MetLife’s non-management director fee arrangements.
MetLife Inc. EVP & Chief Risk Officer Marlene Debel reported equity compensation transactions in company common stock. On February 24, 2026, she acquired 15,132 shares at no cost as a restricted stock unit award under MetLife’s 2025 Stock and Incentive Compensation Plan and 14,870 shares from the performance-based payout of a 2023–2025 performance share award.
On the same date, 5,624 shares at $75.34 per share were withheld to cover her tax obligations related to the performance share payout. After these transactions, she directly owned 158,513 MetLife common shares. These movements reflect stock-based compensation and related tax withholding, not open‑market buying or selling.
MetLife Inc EVP & Chief Legal Officer Monica M. Curtis reported equity awards and related tax withholding transactions in company stock. On February 24, 2026, she received a grant of 7,964 shares of common stock as a restricted stock unit award under MetLife’s 2025 Stock and Incentive Compensation Plan.
She also acquired 420 shares of common stock from the performance-based payout of a 2023–2025 performance share award under MetLife’s 2015 Stock and Incentive Compensation Plan. To cover taxes on this performance share payout, 237 shares were withheld at a price of $75.34 per share. After these transactions, her directly held common stock position was reported at 18,599 shares.
MetLife Inc. executive Bill Pappas reported equity awards and related tax withholding transactions in company stock. On February 24, 2026, he acquired 20,508 and 22,866 shares of MetLife common stock at $0 per share through stock awards, and 11,683 shares were withheld at $75.34 per share to cover tax obligations. After these transactions, he directly owned 89,735 shares. The filing also notes additional indirect holdings of 10,220 and 18,750 shares through 2024 and 2025 Grantor Retained Annuity Trusts.
O'Neill Adrienne Karen reported acquisition or exercise transactions in this Form 4 filing.
MetLife Inc executive Adrienne Karen O'Neill, EVP & Chief Accounting Officer, received an equity grant of 2,655 shares of common stock on February 24, 2026. The shares were awarded at $0.00 per share as a restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan, increasing her directly owned holdings to 14,557 shares.
Sibblies Shurawl reported acquisition or exercise transactions in this Form 4 filing.
MetLife Inc executive Sibblies Shurawl received an equity award of 6,372 shares of common stock on February 24, 2026. The shares were granted at a price of $0.00 per share as a restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan, increasing Shurawl’s direct holdings to 28,256 shares.
MetLife Inc President & CEO Michel Khalaf reported stock-based compensation and related tax withholding. He acquired 69,286 shares of common stock through a restricted stock unit award under MetLife’s 2025 Stock and Incentive Compensation Plan and 81,364 shares from the payout of a 2023–2025 performance share award.
To cover tax obligations on the performance share payout, 43,004 shares were withheld at a price of $75.34 per share, treated as a disposition for tax withholding purposes rather than an open-market sale. After these transactions, Khalaf directly owned 720,129 shares of MetLife common stock.
MetLife Inc director Daniel S. Glaser reported an acquisition of 273 shares of MetLife common stock on February 24, 2026 as a grant or award. The shares, valued at $75.34 per share, increased his direct holdings to 1,578 shares and were deferred under MetLife’s non-management director deferred compensation plan.
MetLife EVP & Chief Financial Officer John D. McCallion reported equity awards and related tax withholding in company stock. On February 24, 2026, he acquired 23,892 shares of common stock as a restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan.
On the same date, he acquired 26,934 additional common shares from the performance factor determination and payout of a 2023–2025 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Also on that date, 13,776 shares were disposed of to satisfy his tax withholding obligation on the performance share payout at a price of $75.34 per share.
Following these transactions, McCallion directly owned 282,179 shares of MetLife common stock.
MetLife Inc director Michelle Seitz filed an initial ownership report showing no securities beneficially owned. The Form 3 indicates that, following the reported position, she directly held 0.0000 shares of MetLife common stock, meaning she reported no current equity stake in the company.